A Stanford-led study found that most AI chatbots have stopped including medical disclaimers in health responses, raising ...

A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Once cautious, OpenAI, Grok, and others will now dive into giving unverified medical advice with virtually no disclaimers.

Isomorphic Labs, the AI -powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

OpenEvidence raises $210M on $3.5B valuation to expand AI-powered medical search and decision tools - SiliconANGLE ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling breakthroughs.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

It’s a sentiment felt widely across the medical field as AI starts to touch nearly every corner of medical research, physician training and processes, and patient care. The rollout of AI across health ...

Although patients and the general public were identified as the primary audience, the researchers noted that AI-generated podcasts could serve as a cost-effective, scalable way for healthcare ...